Ai gen fashion
Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Cettire Limited (ASX:CTT) shares jumped on Wednesday morning after the company revealed confirmed FY24 metrics underscoring strong revenue growth.

The online luxury retail provider confirmed – in response to a letter received from the ASX in the recent past – FY24 revenue growth was up 81% to $975M YoY vs $549M in FY23.

The average order value increased up to 7% in FY24 with the average customer spending $800 at a time. Shares jumped 4% in turn to $1.57ea.

Notably, active customers increased 64% to 692K individuals – despite the company being constantly haunted by allegations of selling fakes, or being the subject of AFR investigations alleging a failure to pay cross border taxes.

A full year FY24 report is anticipated to be ready in the second half of August, and anybody who’s just bought into the stock is probably pretty chuffed.

One week returns in the company are up +25%, but, one year returns are down -53% and YTD performance is down -46%. The once billion dollar market cap company currently has a more tame capitalisation at just under $600M.

Cettire has twice fallen from heights over $4/sh to less than one dollar – its volatility is perhaps not unfamiliar for anyone who’s held on for a few years now. Not helping matters is that company chief Dean Mintz likes to sell off large parcels of shares at inopportune times.

The AFR frequently describe him as “reclusive,” which is surely a dog-whistle for something, but what exactly isn’t clear.

CTT last traded at $1.57.

CTT by the numbers
More From The Market Online
Market concept

(Last) Market Close (of 2025): October back again as DRO, EOS & 4DX pop; otherwise mid day

If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s

EV Resources on ‘accelerated pathway’ to Los Lirios restart after strong antimony recovery tests

EV Resources is inching closer to a Los Lirios restart after strong metallurgical results set up…
Magneto scan concept

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big…

Coles, Woolies left furious over gov’t checks designed to limit ‘excessive pricing on groceries’

Coles and Woolworths have come out swinging against the government's plan to impose stricter rules to…